Dexcom (DXCM) Stock Valuation: P/E Ratio and Intrinsic Value
Dexcom share price
| Price (USD) | 82.29 |
|---|---|
| Price date | 2026-10-31 |
| Market capitalization | 31.05 USD bn |
Annual and quarterly filings: SEC EDGAR – Dexcom
Is Dexcom stock expensive or cheap? This page shows the price-earnings ratio of Dexcom for the last fiscal years, the current share price, and beta and volatility as risk measures. Earnings figures come from the company's published filings.
How the Dexcom P/E ratio is calculated
The price-earnings ratio divides the share price by earnings per share. On this page the ratio is shown per fiscal year, so you can see whether today's valuation of Dexcom is above or below its own history. Beta and volatility indicate how strongly the share moves compared with the overall market.
Frequently asked questions about Dexcom
What is the DXCM P/E ratio?
The P/E ratio divides the Dexcom share price by earnings per share. This page shows the ratio for each of the last fiscal years, so the current valuation of DXCM can be compared with its own history.
Is Dexcom stock overvalued or undervalued?
There is no single answer. A useful check is whether the current P/E of DXCM is above or below its multi-year average and how earnings, margins and revenue are developing. This page shows all of these figures from the published filings.
How can I estimate the intrinsic value of Dexcom?
An intrinsic value estimate needs earnings or free cash flow, a growth assumption and a discount rate. This page provides the reported earnings basis, margins and the valuation history of DXCM as the starting point.